Institutional Ownership Oric Pharmaceuticals, Inc. (ORIC)
This table provides information about the institutional ownership of Oric Pharmaceuticals, Inc. (ORIC). We have compiled data on the 157 institutions that hold shares in the stock, with a total of 105 Million shares, which have been reported (via 13F filing form) to have a value of $1.37 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nextech Invest, Ltd.
Zurich, V8 |
Nov 14, 2025 Q3 2025 |
7,162,637
shares
|
$93.8 Million
13.08% of portfolio
|
Q2 2025
Added 35.51%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
6,728,116
shares
|
$88.1 Million
6.03% of portfolio
|
Q3 2025
Added 315.81%
|
|
|
Vr Adviser, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
6,596,885
shares
|
$86.4 Million
11.96% of portfolio
|
Q2 2025
Added 107.28%
|
|
|
Viking Global Investors LP
|
Nov 14, 2025 Q3 2025 |
6,572,700
shares
|
$86 Million
0.22% of portfolio
|
Q1 2025
Added 48.33%
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
5,285,714
shares
|
$69.2 Million
7.95% of portfolio
|
Q1 2024
Added 23.33%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,830,880
shares
|
$63.2 Million
0.0% of portfolio
|
Q2 2024
Added 52.0%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
4,650,138
shares
|
$60.9 Million
0.0% of portfolio
|
Q3 2025
Added 48.82%
|
|
|
Sr One Capital Management, LP
|
Nov 12, 2025 Q3 2025 |
4,514,929
shares
|
$59.1 Million
12.39% of portfolio
|
Q2 2025
New holding
|
|
|
Alkeon Capital Management LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
4,504,096
shares
|
$59 Million
0.08% of portfolio
|
Q2 2025
Added 12.49%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Nov 14, 2025 Q3 2025 |
4,118,621
shares
|
$53.9 Million
3.07% of portfolio
|
Q2 2025
Added 87.59%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
3,641,756
shares
|
$47.7 Million
1.48% of portfolio
|
Q3 2025
Added 304.96%
|
|
|
Column Group LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
3,540,777
shares
|
$46.3 Million
53.36% of portfolio
|
Q1 2024
Reduced 0.77%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
3,126,604
shares
|
$40.9 Million
5.93% of portfolio
|
Q2 2025
Added 50.28%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
2,871,327
shares
|
$37.6 Million
0.0% of portfolio
|
Q3 2025
Added 3.92%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Nov 14, 2025 Q3 2025 |
2,619,914
shares
|
$34.3 Million
0.06% of portfolio
|
Q3 2025
Reduced 8.09%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
2,403,939
shares
|
$31.5 Million
0.0% of portfolio
|
Q3 2025
Added 47.29%
|
|
|
First Turn Management, LLC
Del Mar, CA |
Nov 14, 2025 Q3 2025 |
2,159,474
shares
|
$28.3 Million
3.89% of portfolio
|
Q3 2025
Added 7.44%
|
|
|
Silverarc Capital Management, LLC
|
Nov 12, 2025 Q3 2025 |
1,948,808
shares
|
$25.5 Million
4.79% of portfolio
|
Q3 2025
Added 8.22%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
1,729,378
shares
|
$22.6 Million
3.74% of portfolio
|
Q2 2025
Added 23.57%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,630,744
shares
|
$21.3 Million
0.0% of portfolio
|
Q3 2025
Added 47.12%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,519,314
shares
|
$19.9 Million
0.03% of portfolio
|
Q3 2025
Reduced 14.54%
|
|
|
Royce & Associates LP
|
Nov 12, 2025 Q3 2025 |
1,458,483
shares
|
$19.1 Million
0.19% of portfolio
|
Q3 2025
Added 521.23%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
1,228,528
shares
|
$16.1 Million
0.0% of portfolio
|
Q3 2025
Added 3346.18%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
1,198,004
shares
|
$15.7 Million
0.0% of portfolio
|
Q3 2025
Reduced 14.6%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
1,181,329
shares
|
$15.5 Million
0.0% of portfolio
|
Q3 2025
Added 13.31%
|
|